[
  {
    "title": "With 67% ownership of the shares, Pfizer Inc. (NYSE:PFE) is heavily dominated by institutional owners",
    "link": "https://finance.yahoo.com/news/67-ownership-shares-pfizer-inc-140012393.html"
  },
  {
    "title": "Is Pfizer Stock a Buy After This $1.25 Billion Investment?",
    "link": "https://finance.yahoo.com/news/pfizer-stock-buy-1-25-140000394.html"
  },
  {
    "title": "Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-trending-stock-130012159.html"
  },
  {
    "title": "Pfizer headquarters conversion project in Manhattan gets $720m loan",
    "link": "https://finance.yahoo.com/news/pfizer-headquarters-conversion-project-manhattan-092111893.html"
  },
  {
    "title": "Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer",
    "link": "https://finance.yahoo.com/news/roche-gets-chmp-nod-itovebi-133800542.html"
  },
  {
    "title": "Junkiest Junk Is Offering a Warning Sign for Debt",
    "link": "https://finance.yahoo.com/news/junkiest-junk-offering-warning-sign-190000986.html"
  },
  {
    "title": "Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-delivers-oncology-145939821.html"
  },
  {
    "title": "Down 63%, Should You Buy the Dip on Pfizer?",
    "link": "https://finance.yahoo.com/news/down-63-buy-dip-pfizer-124500642.html"
  },
  {
    "title": "Charting the Global Economy: Long-Term Bond Yields Soar Around the World",
    "link": "https://finance.yahoo.com/news/charting-global-economy-long-term-090000717.html"
  },
  {
    "title": "1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist",
    "link": "https://finance.yahoo.com/news/1-ultra-high-yield-dividend-085100227.html"
  },
  {
    "title": "U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result",
    "link": "https://finance.yahoo.com/news/u-pharmaceutical-imports-might-soon-081100447.html"
  },
  {
    "title": "Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication",
    "link": "https://finance.yahoo.com/news/roche-gets-fda-nod-label-200200599.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Showcases New Cancer Treatment Study And Reports Prostate Cancer Drug Success",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-showcases-cancer-173313300.html"
  },
  {
    "title": "Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More",
    "link": "https://finance.yahoo.com/news/pharma-stock-roundup-nvo-ceo-121600064.html"
  },
  {
    "title": "Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial",
    "link": "https://finance.yahoo.com/news/astellas-pfizer-xtandi-combo-reduces-093124125.html"
  },
  {
    "title": "Was Jim Cramer Right About Pfizer Inc. (PFE)?",
    "link": "https://finance.yahoo.com/news/jim-cramer-pfizer-inc-pfe-203621375.html"
  },
  {
    "title": "Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer",
    "link": "https://finance.yahoo.com/news/astellas-pfizers-xtandi-enzalutamide-shows-210000931.html"
  },
  {
    "title": "MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot",
    "link": "https://finance.yahoo.com/news/mrna-stock-down-withdrawal-fda-144800564.html"
  },
  {
    "title": "5 Low Price-to-Sales Stocks That Can Deliver Big Returns in 2025",
    "link": "https://finance.yahoo.com/news/5-low-price-sales-stocks-114200049.html"
  },
  {
    "title": "Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Corcept (NASDAQ:CORT)",
    "link": "https://finance.yahoo.com/news/branded-pharmaceuticals-stocks-q1-results-033100190.html"
  },
  {
    "title": "Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds",
    "link": "https://finance.yahoo.com/news/citi-maintains-hold-rating-pfizer-203253784.html"
  },
  {
    "title": "Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal",
    "link": "https://finance.yahoo.com/news/bernstein-reaffirms-pfizer-rating-6b-182204340.html"
  },
  {
    "title": "Home Depot backs outlook as U.S. sales ticked up: Morning Buzz",
    "link": "https://finance.yahoo.com/news/home-depot-backs-outlook-u-155534510.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-130800026.html"
  },
  {
    "title": "MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots",
    "link": "https://finance.yahoo.com/news/mrna-pfe-stocks-jump-despite-123700324.html"
  },
  {
    "title": "Giant US companies are rushing to Europe to borrow money",
    "link": "https://finance.yahoo.com/news/giant-us-companies-rushing-europe-110024297.html"
  },
  {
    "title": "2 High-Yield Dividend Stocks to Buy Right Now",
    "link": "https://finance.yahoo.com/news/2-high-yield-dividend-stocks-102300632.html"
  },
  {
    "title": "Stocks to Watch Recap: Home Depot, Tesla, Uber, UnitedHealth",
    "link": "https://finance.yahoo.com/m/25c86e99-6728-30a9-8c90-58a0935ee862/stocks-to-watch-recap-home.html"
  },
  {
    "title": "Trump's Drug Price War Could Slash Big Pharma Profits",
    "link": "https://finance.yahoo.com/news/trumps-drug-price-war-could-201348028.html"
  },
  {
    "title": "BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock",
    "link": "https://finance.yahoo.com/news/bmo-capital-maintains-buy-rating-201036572.html"
  },
  {
    "title": "COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers",
    "link": "https://finance.yahoo.com/video/covid-vaccine-guidelines-d-wave-195530989.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-180254366.html"
  },
  {
    "title": "Bitcoin gains, FDA's vaccine guidance, UnitedHealth recovers",
    "link": "https://finance.yahoo.com/video/bitcoin-gains-fdas-vaccine-guidance-171235329.html"
  },
  {
    "title": "The FDA Is Limiting Covid Shots. But Moderna, Vaccine Stocks Jumped.",
    "link": "https://finance.yahoo.com/m/11c68f88-0a19-35ef-92db-976c9687f359/the-fda-is-limiting-covid.html"
  },
  {
    "title": "Pfizer Is Jumping Into a Hot Cancer-Drug Race. It May Have Overpaid.",
    "link": "https://finance.yahoo.com/m/605f4971-fc24-3e81-8e19-411d642b62c1/pfizer-is-jumping-into-a-hot.html"
  },
  {
    "title": "MRK, Daiichi Begin Pivotal Esophageal Cancer Study With ADC Drug",
    "link": "https://finance.yahoo.com/news/mrk-daiichi-begin-pivotal-esophageal-142200984.html"
  },
  {
    "title": "Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China",
    "link": "https://finance.yahoo.com/news/pfizer-inks-6b-deal-market-133447657.html"
  },
  {
    "title": "Buy 3 Wide Moat Stocks With Double-Digit Near-Term Upside Potential",
    "link": "https://finance.yahoo.com/news/buy-3-wide-moat-stocks-130000956.html"
  },
  {
    "title": "Pfizer Buys Rights to PD-1 & VEGF Inhibitor From China Biotech",
    "link": "https://finance.yahoo.com/news/pfizer-buys-rights-pd-1-124600019.html"
  },
  {
    "title": "Pfizer Strikes up to $6.05 Billion Licensing Deal for 3SBio's Cancer Drug Candidate",
    "link": "https://finance.yahoo.com/news/pfizer-strikes-6-05-billion-103211976.html"
  },
  {
    "title": "Pfizer Signs Experimental Drug Licensing Agreement With 3SBio",
    "link": "https://finance.yahoo.com/news/pfizer-signs-experimental-drug-licensing-102800265.html"
  },
  {
    "title": "Pfizer buys into PD-1/VEGF competition with 3SBio deal",
    "link": "https://finance.yahoo.com/news/pfizer-buys-pd-1-vegf-100000406.html"
  },
  {
    "title": "Trending tickers: Microsoft, Pfizer, Foxconn, CATL and Vodafone",
    "link": "https://finance.yahoo.com/news/microsoft-pfizer-foxconn-catl-and-vodafone-trending-tickers-095021338.html"
  },
  {
    "title": "Pfizer signs global licensing deal with 3SBio for bispecific antibody",
    "link": "https://finance.yahoo.com/news/pfizer-signs-global-licensing-deal-083732608.html"
  },
  {
    "title": "These 3 Dividend Stocks Yield More Than 6% and Their Payouts Look Safe",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-yield-more-075000458.html"
  },
  {
    "title": "Pfizer Inc. (PFE) Inks $6 Billion Cancer Drug Licensing Agreement with China’s 3SBio",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-inks-6-035805800.html"
  },
  {
    "title": "Pfizer in deal with China's 3SBio to license cancer drug candidate, take equity stake",
    "link": "https://finance.yahoo.com/news/pfizer-signs-licensing-deal-worth-003547986.html"
  },
  {
    "title": "Pfizer Enters into Exclusive Licensing Agreement with 3SBio",
    "link": "https://finance.yahoo.com/news/pfizer-enters-exclusive-licensing-agreement-000000302.html"
  },
  {
    "title": "PFE vs. MRK: Which Oncology Drug Giant is a Better Buy Now?",
    "link": "https://finance.yahoo.com/news/pfe-vs-mrk-oncology-drug-122900130.html"
  },
  {
    "title": "1 Profitable Stock on Our Watchlist and 2 to Turn Down",
    "link": "https://finance.yahoo.com/news/1-profitable-stock-watchlist-2-044036031.html"
  },
  {
    "title": "Don't Fall for These 3 Dividend Stocks: They May Have to Make a Cut.",
    "link": "https://finance.yahoo.com/news/dont-fall-3-dividend-stocks-160500110.html"
  },
  {
    "title": "Lawmakers investigating allegations on timing of Pfizer COVID vaccine, WSJ says",
    "link": "https://finance.yahoo.com/news/lawmakers-investigating-allegations-timing-pfizer-153148756.html"
  },
  {
    "title": "Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-attracting-investor-130013104.html"
  },
  {
    "title": "Does Pfizer (NYSE:PFE) Have A Healthy Balance Sheet?",
    "link": "https://finance.yahoo.com/news/does-pfizer-nyse-pfe-healthy-120026137.html"
  },
  {
    "title": "Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income",
    "link": "https://finance.yahoo.com/news/heres-many-shares-pfizer-own-084900166.html"
  },
  {
    "title": "Update: Market Chatter: US House Panel Says Ex-Pfizer Scientist Confirmed Involvement in Delaying COVID-19 Vaccine Results",
    "link": "https://finance.yahoo.com/news/market-chatter-us-house-panel-173256249.html"
  },
  {
    "title": "New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel",
    "link": "https://finance.yahoo.com/m/0037387f-43fd-3ff8-9c0b-e33b724563d2/new-allegations-about-timing.html"
  },
  {
    "title": "5 Low Price-to-Book Value Stocks to Buy in May",
    "link": "https://finance.yahoo.com/news/5-low-price-book-value-123600277.html"
  },
  {
    "title": "FDA delays approval decision for Biohaven rare disease drug",
    "link": "https://finance.yahoo.com/news/fda-delays-approval-decision-biohaven-122700409.html"
  },
  {
    "title": "3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/3-magnificent-p-500-dividend-220500550.html"
  },
  {
    "title": "Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”",
    "link": "https://finance.yahoo.com/news/jim-cramer-pfizer-pfe-caught-141553105.html"
  },
  {
    "title": "Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-stoneco-114600737.html"
  },
  {
    "title": "3 Value Stocks Facing Headwinds",
    "link": "https://finance.yahoo.com/news/3-value-stocks-facing-headwinds-043531457.html"
  },
  {
    "title": "Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom",
    "link": "https://finance.yahoo.com/news/why-pfizer-inc-pfe-among-210727451.html"
  },
  {
    "title": "PFE vs. LLY: Which Stock Is the Better Value Option?",
    "link": "https://finance.yahoo.com/news/pfe-vs-lly-stock-better-154010141.html"
  },
  {
    "title": "Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.",
    "link": "https://finance.yahoo.com/m/23918c9e-3c4d-3cd4-9d90-726c71a99d5f/pfizer-eli-lilly-and-other.html"
  },
  {
    "title": "4 Value Picks to Ride the Market Rebound After US-China Trade Thaw",
    "link": "https://finance.yahoo.com/news/4-value-picks-ride-market-143700033.html"
  },
  {
    "title": "Should Value Investors Buy Pfizer (PFE) Stock?",
    "link": "https://finance.yahoo.com/news/value-investors-buy-pfizer-pfe-134015844.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights J&J, Eli Lilly, Pfizer, Merck, Amgen",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-j-132200138.html"
  },
  {
    "title": "Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared",
    "link": "https://finance.yahoo.com/news/drug-stocks-recover-trumps-order-113600111.html"
  },
  {
    "title": "PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity",
    "link": "https://finance.yahoo.com/news/pfe-q1-earnings-call-revenue-102123036.html"
  },
  {
    "title": "Trump's drug price order is part request, part threat: Analyst",
    "link": "https://finance.yahoo.com/video/trumps-drug-price-order-part-232000676.html"
  },
  {
    "title": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "link": "https://finance.yahoo.com/m/1b14d492-f15c-39ae-a253-f4ee9a3ca80b/these-stocks-moved-the-most.html"
  },
  {
    "title": "How Trump could go about executing order to slash drug prices",
    "link": "https://finance.yahoo.com/video/trump-could-executing-order-slash-195046744.html"
  },
  {
    "title": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "link": "https://finance.yahoo.com/m/987352d5-6779-36ef-9e14-e8db473744e8/trump-executive-order-could.html"
  },
  {
    "title": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
    "link": "https://finance.yahoo.com/news/drug-wars-wall-street-says-big-questions-remain-about-impact-of-trumps-new-pricing-order-163455794.html"
  },
  {
    "title": "Trump expected to sign order to slash US drug prices",
    "link": "https://finance.yahoo.com/video/trump-expected-sign-order-slash-144432389.html"
  },
  {
    "title": "Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-pcb-132500742.html"
  },
  {
    "title": "US-China trade truce, April CPI, drug prices: 3 Things",
    "link": "https://finance.yahoo.com/video/us-china-trade-truce-april-130939738.html"
  },
  {
    "title": "Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW",
    "link": "https://finance.yahoo.com/news/zacks-market-edge-highlights-whr-125000304.html"
  },
  {
    "title": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
    "link": "https://finance.yahoo.com/news/trump-vows-us-drug-price-070150001.html"
  },
  {
    "title": "Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks",
    "link": "https://finance.yahoo.com/m/094e22d2-59fc-31a6-89f9-aad53f55c524/trump%E2%80%99s-plan-to-cut-drug.html"
  },
  {
    "title": "Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings",
    "link": "https://finance.yahoo.com/news/shareholders-pleased-quality-pfizers-nyse-111151734.html"
  },
  {
    "title": "Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices",
    "link": "https://finance.yahoo.com/news/pharma-shares-fall-pre-bell-095515844.html"
  },
  {
    "title": "Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.",
    "link": "https://finance.yahoo.com/news/wondering-pfizers-7-6-dividend-085100613.html"
  },
  {
    "title": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
    "link": "https://finance.yahoo.com/news/asia-pharma-stocks-drop-trump-024422723.html"
  },
  {
    "title": "Investors three-year losses continue as Pfizer (NYSE:PFE) dips a further 7.9% this week, earnings continue to decline",
    "link": "https://finance.yahoo.com/news/investors-three-losses-continue-pfizer-120023306.html"
  },
  {
    "title": "3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever",
    "link": "https://finance.yahoo.com/news/3-magnificent-p-500-dividend-093900342.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-best-high-081713478.html"
  },
  {
    "title": "Are Your Mega-High Stock Dividends Safe?",
    "link": "https://finance.yahoo.com/news/mega-high-stock-dividends-safe-164400330.html"
  },
  {
    "title": "Pfizer (PFE) Just Overtook the 20-Day Moving Average",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-just-overtook-20-135503577.html"
  },
  {
    "title": "Was Jim Cramer Right About Pfizer (PFE)?",
    "link": "https://finance.yahoo.com/news/jim-cramer-pfizer-pfe-122318072.html"
  },
  {
    "title": "5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio",
    "link": "https://finance.yahoo.com/news/5-low-price-sales-stocks-121200725.html"
  },
  {
    "title": "If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?",
    "link": "https://finance.yahoo.com/news/invested-10k-pfizer-stock-10-020150823.html"
  },
  {
    "title": "A Look at Pharma ETFs After Strong Q1 Earnings",
    "link": "https://finance.yahoo.com/news/look-pharma-etfs-strong-q1-155000613.html"
  },
  {
    "title": "Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-climb-25-14-135508966.html"
  },
  {
    "title": "Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks",
    "link": "https://finance.yahoo.com/news/want-3-100-annual-dividends-094500051.html"
  },
  {
    "title": "Alnylam keeps pushing the rare disease paradigm as RNAi promises even wider indications",
    "link": "https://finance.yahoo.com/news/alnylam-keeps-pushing-rare-disease-080000891.html"
  },
  {
    "title": "FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight",
    "link": "https://finance.yahoo.com/news/fda-expands-surprise-inspections-foreign-185407796.html"
  },
  {
    "title": "Jim Cramer on Pfizer (PFE): “Trying Big Targets, but New Wins Still Elusive”",
    "link": "https://finance.yahoo.com/news/jim-cramer-pfizer-pfe-trying-175025216.html"
  },
  {
    "title": "Trump Is Threatening Big Pharma With Tariffs. Tax Changes Might Work Better.",
    "link": "https://finance.yahoo.com/m/a4bec800-6f4b-30e9-8edf-e6305a9166c4/trump-is-threatening-big.html"
  },
  {
    "title": "Market Chatter: Expanded Indication for GSK, Pfizer RSV Vaccines Faces Government Review",
    "link": "https://finance.yahoo.com/news/market-chatter-expanded-indication-gsk-201334412.html"
  },
  {
    "title": "Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers.",
    "link": "https://finance.yahoo.com/m/4905bd6c-d6c2-31c3-8bdf-25145b8cfb69/trump-sets-pharma-tariffs.html"
  },
  {
    "title": "Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1",
    "link": "https://finance.yahoo.com/news/moderna-sharpens-pipeline-focus-covid-135400467.html"
  },
  {
    "title": "Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend",
    "link": "https://finance.yahoo.com/news/3-checks-buying-pfizer-inc-131303373.html"
  },
  {
    "title": "Why Viking Therapeutics Stock Surged Nearly 20% Higher in April",
    "link": "https://finance.yahoo.com/news/why-viking-therapeutics-stock-surged-083331825.html"
  },
  {
    "title": "Optimism Is Back for Biotech Stocks. This Time, It Could Last.",
    "link": "https://finance.yahoo.com/m/9e07f027-7fa1-3b86-9f03-26df8aa0eb8f/optimism-is-back-for-biotech.html"
  },
  {
    "title": "Top Wide-Moat Stocks to Invest in for Long-Term Growth",
    "link": "https://finance.yahoo.com/news/top-wide-moat-stocks-invest-122200214.html"
  },
  {
    "title": "Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold?",
    "link": "https://finance.yahoo.com/news/pfizer-stock-5-following-q1-121000525.html"
  },
  {
    "title": "Is Pfizer Inc. (PFE) The Most Profitable Cheap Stock to Buy Now?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-most-profitable-152058132.html"
  },
  {
    "title": "Is Pfizer Inc.'s (NYSE:PFE) Stock Price Struggling As A Result Of Its Mixed Financials?",
    "link": "https://finance.yahoo.com/news/pfizer-inc-nyse-pfe-stock-120028400.html"
  },
  {
    "title": "Trump Says Drug Tariffs Are Coming. Big Pharma Execs Can’t Figure Out How Much to Worry.",
    "link": "https://finance.yahoo.com/m/64ec4ca8-6882-3966-87c1-a6c7fec387aa/trump-says-drug-tariffs-are.html"
  },
  {
    "title": "Zacks.com featured highlights Fox, Universal Technical Institute, Pfizer, Tenet Healthcare and Newmont",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-fox-125900043.html"
  },
  {
    "title": "3 No-Brainer Ultra-High-Yield Dividend Stocks That Are Begging to Be Bought in May",
    "link": "https://finance.yahoo.com/news/3-no-brainer-ultra-high-075100013.html"
  },
  {
    "title": "Arvinas Inc (ARVN) Q1 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...",
    "link": "https://finance.yahoo.com/news/arvinas-inc-arvn-q1-2025-070309524.html"
  },
  {
    "title": "'Declare victory and move on': Eli Lilly CEO on Trump tariff threat",
    "link": "https://finance.yahoo.com/news/declare-victory-and-move-on-eli-lilly-ceo-on-trump-tariff-threat-160646465.html"
  },
  {
    "title": "LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down",
    "link": "https://finance.yahoo.com/news/llys-q1-earnings-miss-mounjaro-155100125.html"
  },
  {
    "title": "Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance",
    "link": "https://finance.yahoo.com/news/eli-lilly-stock-slips-despite-earnings-beat-reaffirmed-2025-guidance-125448495.html"
  },
  {
    "title": "Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks",
    "link": "https://finance.yahoo.com/news/looking-earnings-beat-buy-5-124000418.html"
  },
  {
    "title": "Zacks.com featured highlights Centene, Pediatrix Medical, Pfizer, StoneCo and Banco Santander",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-centene-085000527.html"
  },
  {
    "title": "Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 3 Ultra-High-Yield Stocks.",
    "link": "https://finance.yahoo.com/news/want-safe-dividend-income-2025-081500424.html"
  },
  {
    "title": "OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...",
    "link": "https://finance.yahoo.com/news/opko-health-inc-opk-q1-071721036.html"
  },
  {
    "title": "BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations",
    "link": "https://finance.yahoo.com/m/5a8020c0-f8e0-3328-a8d5-da7ff63f15de/bridgebio-breaks-out-after.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Reports Q1 Earnings, Reaffirms 2025 Revenue Guidance at US$61-64 Billion",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-reports-q1-173235366.html"
  },
  {
    "title": "Company News for Apr 30, 2025",
    "link": "https://finance.yahoo.com/news/company-news-apr-30-2025-131000899.html"
  },
  {
    "title": "Boost Your Portfolio With These 5 Low Price-to-Book Stocks",
    "link": "https://finance.yahoo.com/news/boost-portfolio-5-low-price-130800068.html"
  },
  {
    "title": "Pfizer First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag",
    "link": "https://finance.yahoo.com/news/pfizer-first-quarter-2025-earnings-123725913.html"
  },
  {
    "title": "BridgeBio sales of new heart drug outstrip expectations",
    "link": "https://finance.yahoo.com/news/bridgebio-sales-heart-drug-outstrip-110714431.html"
  },
  {
    "title": "Stock Market Crash: 3 Absurdly Cheap Stocks to Load Up on for the Long Haul",
    "link": "https://finance.yahoo.com/news/stock-market-crash-3-absurdly-110500153.html"
  },
  {
    "title": "Market Rally at Risk as Tariffs Damage Spreads. And 5 Other Things to Know Today.",
    "link": "https://finance.yahoo.com/m/3911d47e-6f63-3408-a9ab-1f314de4849e/market-rally-at-risk-as.html"
  },
  {
    "title": "Pfizer's Dividend Yield Is 7.5%. Is It Still Safe?",
    "link": "https://finance.yahoo.com/news/pfizers-dividend-yield-7-5-101500533.html"
  },
  {
    "title": "Will Pfizer Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?",
    "link": "https://finance.yahoo.com/news/pfizer-acquire-altimmune-viking-therapeutics-085100117.html"
  },
  {
    "title": "Is Healthcare Losing the Status of Safe Haven? ETFs in Focus",
    "link": "https://finance.yahoo.com/news/healthcare-losing-status-safe-haven-083300838.html"
  },
  {
    "title": "Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain",
    "link": "https://finance.yahoo.com/news/prediction-pfizers-loss-may-viking-071500884.html"
  },
  {
    "title": "Pfizer Inc (PFE) Q1 2025 Earnings Call Highlights: Navigating Revenue Decline and Strategic Growth",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-q1-2025-071156962.html"
  },
  {
    "title": "Buy Pfizer (PFE) Stock for a Rebound After Crushing Q1 EPS Expectations?",
    "link": "https://finance.yahoo.com/news/buy-pfizer-pfe-stock-rebound-003200844.html"
  },
  {
    "title": "Stock Bulls Fuel Best Winning Run Since March 2022: Markets Wrap",
    "link": "https://finance.yahoo.com/news/asian-stocks-edge-barrage-earnings-014255977.html"
  },
  {
    "title": "These Stocks Moved the Most Today: GM, Tesla, Ford, JetBlue, Wolfspeed, SoFi, Nvidia, and More",
    "link": "https://finance.yahoo.com/m/f0c0f99a-882a-3f36-a29b-6bb39cba2324/these-stocks-moved-the-most.html"
  },
  {
    "title": "S&P 500 Stock Pfizer Jumps As Cost-Cutting Bolsters Profit",
    "link": "https://finance.yahoo.com/m/6fd58dae-7780-3d61-b4c8-f887cc9e55e5/s-p-500-stock-pfizer-jumps-as.html"
  },
  {
    "title": "Pfizer Shares Rise on CEO’s Optimism on Threatened Drug Tariffs",
    "link": "https://finance.yahoo.com/m/039e09ae-1aef-3d03-8d50-a51058213dca/pfizer-shares-rise-on-ceo%E2%80%99s.html"
  },
  {
    "title": "Pfizer Cuts Spending on Weaker Sales",
    "link": "https://finance.yahoo.com/video/pfizer-cuts-spending-weaker-sales-192049405.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Higher Tuesday Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-higher-181755135.html"
  },
  {
    "title": "Pfizer Stock’s 7% Yield Makes It Look Like a Junk Bond—But Better",
    "link": "https://finance.yahoo.com/m/79b51aff-f5e1-3bfd-b3d1-b1d0c2e01990/pfizer-stock%E2%80%99s-7-yield-makes.html"
  },
  {
    "title": "Pfizer Expands Cost-Cutting Measures, Reaffirms Outlook",
    "link": "https://finance.yahoo.com/m/aa09cf82-9814-3446-8d0e-8f482d6bc027/pfizer-expands-cost-cutting.html"
  },
  {
    "title": "Pfizer CEO: 'We should not have tariffs' on pharma",
    "link": "https://finance.yahoo.com/news/pfizer-ceo-we-should-not-have-tariffs-on-pharma-171641146.html"
  },
  {
    "title": "Pfizer Shares Rise After Q1 Profit Beats, Reaffirms 2025 Outlook",
    "link": "https://finance.yahoo.com/news/pfizer-shares-rise-q1-profit-163604707.html"
  },
  {
    "title": "Pfizer Q1 Earnings Beat Estimates, Several Headwinds Hurt Sales",
    "link": "https://finance.yahoo.com/news/pfizer-q1-earnings-beat-estimates-153400888.html"
  },
  {
    "title": "Economic Data Deluge",
    "link": "https://finance.yahoo.com/news/economic-data-deluge-151100432.html"
  },
  {
    "title": "Pfizer Reports Mixed First Quarter, Affirms Full-Year Outlook",
    "link": "https://finance.yahoo.com/news/pfizer-reports-mixed-first-quarter-144710844.html"
  },
  {
    "title": "Pfizer Eyes Acquisitions After Obesity Drug Setback",
    "link": "https://finance.yahoo.com/news/pfizer-eyes-acquisitions-obesity-drug-143221205.html"
  },
  {
    "title": "Pfizer offers 'longer-term' opportunity amid tariff uncertainty",
    "link": "https://finance.yahoo.com/video/pfizer-offers-longer-term-opportunity-143115195.html"
  },
  {
    "title": "Trade Balance in Goods Hits All-Time Record, Plus Q1 Earnings",
    "link": "https://finance.yahoo.com/news/trade-balance-goods-hits-time-142900578.html"
  },
  {
    "title": "Compared to Estimates, Pfizer (PFE) Q1 Earnings: A Look at Key Metrics",
    "link": "https://finance.yahoo.com/news/compared-estimates-pfizer-pfe-q1-140006837.html"
  },
  {
    "title": "GM, UPS, Coca-Cola, Spotify: Stocks to watch today",
    "link": "https://finance.yahoo.com/news/gm-ups-coca-cola-spotify-131400329.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Misses Q1 Revenue Estimates",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-misses-q1-122415597.html"
  },
  {
    "title": "Pfizer’s Bourla ‘cautiously optimistic’ on looming US pharma tariffs",
    "link": "https://finance.yahoo.com/news/pfizer-bourla-cautiously-optimistic-looming-121700979.html"
  },
  {
    "title": "Pfizer (PFE) Surpasses Q1 Earnings Estimates",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-surpasses-q1-earnings-115504229.html"
  },
  {
    "title": "If You'd Invested $10,000 in Pfizer Stock 10 Years Ago, Here's How Much You'd Have Today",
    "link": "https://finance.yahoo.com/news/youd-invested-10-000-pfizer-114500857.html"
  },
  {
    "title": "Biohaven secures $600m financing as it awaits FDA prodrug decision",
    "link": "https://finance.yahoo.com/news/biohaven-secures-600m-financing-awaits-110621672.html"
  },
  {
    "title": "Pfizer reports mixed results in first quarter earnings, reiterates 2025 outlook",
    "link": "https://finance.yahoo.com/news/pfizer-reports-mixed-results-in-first-quarter-earnings-reiterates-2025-outlook-105736856.html"
  },
  {
    "title": "Pfizer: Q1 Earnings Snapshot",
    "link": "https://finance.yahoo.com/news/pfizer-q1-earnings-snapshot-105514725.html"
  },
  {
    "title": "Pfizer leans on cost cuts to offset falling revenue",
    "link": "https://finance.yahoo.com/news/pfizer-beats-profit-estimates-cost-105349474.html"
  },
  {
    "title": "Pfizer Reports Solid First-Quarter 2025 Results And Reaffirms 2025 Guidance",
    "link": "https://finance.yahoo.com/news/pfizer-reports-solid-first-quarter-104500122.html"
  },
  {
    "title": "US Stock Futures Edge Higher Tuesday: Expert Warns Of 'Perfect Volatility Storm' With Major Earnings And Economic Data Due This Week",
    "link": "https://finance.yahoo.com/news/us-stock-futures-edge-higher-103256866.html"
  },
  {
    "title": "The Zacks Analyst Blog Highlights Pfizer, Eli Lilly, Amgen, Biogen and Regeneron",
    "link": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-pfizer-103200684.html"
  },
  {
    "title": "Zacks.com featured highlights StoneCo, Carriage Services, Associated Banc-Corp and Pfizer",
    "link": "https://finance.yahoo.com/news/zacks-com-featured-highlights-stoneco-090800568.html"
  },
  {
    "title": "Coca-Cola earnings, JOLTS, Consumer Confidence: What to Watch",
    "link": "https://finance.yahoo.com/video/coca-cola-earnings-jolts-consumer-230000860.html"
  },
  {
    "title": "Pfizer Q1 Preview: EPS, Revenue Slide Expected",
    "link": "https://finance.yahoo.com/news/pfizer-q1-preview-eps-revenue-195137364.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Unveils Promising Preclinical Data On First-In-Class Oncology Drug",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-unveils-promising-173724581.html"
  },
  {
    "title": "Will These 5 Big Drug Stocks Surpass Q1 Earnings Forecasts?",
    "link": "https://finance.yahoo.com/news/5-big-drug-stocks-surpass-160800036.html"
  },
  {
    "title": "Eli Lilly, Pfizer Risk Billions in Losses From Trump's 25% Pharma Tariffs",
    "link": "https://finance.yahoo.com/news/eli-lilly-pfizer-risk-billions-152037442.html"
  },
  {
    "title": "4 Top Value Stocks to Invest in as US-Global Trade Talks Unfold",
    "link": "https://finance.yahoo.com/news/4-top-value-stocks-invest-121700241.html"
  },
  {
    "title": "3 Dividend Stocks to Buy and Hold for the Next Decade",
    "link": "https://finance.yahoo.com/news/3-dividend-stocks-buy-hold-114700146.html"
  },
  {
    "title": "Pfizer’s sasanlimab and BCG combo therapy improves EFS in bladder cancer trial",
    "link": "https://finance.yahoo.com/news/pfizer-sasanlimab-bcg-combo-therapy-104404691.html"
  },
  {
    "title": "My 5 Top Stocks to Buy Right Now in This Highly Volatile Market",
    "link": "https://finance.yahoo.com/news/5-top-stocks-buy-now-084800780.html"
  },
  {
    "title": "Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-reports-q1-everything-070739798.html"
  },
  {
    "title": "Pfizer Inc. (PFE): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential",
    "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-among-billionaire-190445273.html"
  },
  {
    "title": "1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer",
    "link": "https://finance.yahoo.com/news/1-stock-buy-1-stock-132043391.html"
  },
  {
    "title": "Pfizer’s Sasanlimab Combination Significantly Improves Event-Free Survival in BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer",
    "link": "https://finance.yahoo.com/news/pfizer-sasanlimab-combination-significantly-improves-173000786.html"
  },
  {
    "title": "Investing Action Plan: Apple, Amazon, Pfizer, Caterpillar And Sparring With The Fed",
    "link": "https://finance.yahoo.com/m/8a14136c-151e-3e34-8509-e681b8857b6a/investing-action-plan-apple-.html"
  },
  {
    "title": "Biohaven stock slides on withdrawal of European marketing application",
    "link": "https://finance.yahoo.com/news/biohaven-stock-slides-withdrawal-european-150000873.html"
  },
  {
    "title": "Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season?",
    "link": "https://finance.yahoo.com/news/pfizers-non-covid-drugs-drive-110600199.html"
  },
  {
    "title": "Stocks to watch this week: Apple, Microsoft, Shell, HSBC, Lloyds and AstraZeneca",
    "link": "https://finance.yahoo.com/news/apple-microsoft-shell-hsbc-lloyds-astrazeneca-stocks-to-watch-050019911.html"
  },
  {
    "title": "Sector Update: Health Care Stocks Rise Late Afternoon",
    "link": "https://finance.yahoo.com/news/sector-health-care-stocks-rise-200558091.html"
  },
  {
    "title": "Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform",
    "link": "https://finance.yahoo.com/news/guardant-health-pfizer-collaborate-develop-193634667.html"
  },
  {
    "title": "Pfizer (NYSE:PFE) Collaborates With Guardant Health on Oncology; Declares US$0.43 Dividend",
    "link": "https://finance.yahoo.com/news/pfizer-nyse-pfe-collaborates-guardant-175629624.html"
  },
  {
    "title": "Is Pfizer Stock A Sell After Abandoning Yet Another Obesity Drug?",
    "link": "https://finance.yahoo.com/m/9a6f7dfd-febf-37fb-912a-e0504d778fbc/is-pfizer-stock-a-sell-after.html"
  },
  {
    "title": "PFE vs. LLY: Which Stock Should Value Investors Buy Now?",
    "link": "https://finance.yahoo.com/news/pfe-vs-lly-stock-value-154005499.html"
  },
  {
    "title": "Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release",
    "link": "https://finance.yahoo.com/news/eli-lilly-lly-earnings-expected-140156989.html"
  },
  {
    "title": "Are Investors Undervaluing Pfizer (PFE) Right Now?",
    "link": "https://finance.yahoo.com/news/investors-undervaluing-pfizer-pfe-now-134012549.html"
  },
  {
    "title": "Curious about Pfizer (PFE) Q1 Performance? Explore Wall Street Estimates for Key Metrics",
    "link": "https://finance.yahoo.com/news/curious-pfizer-pfe-q1-performance-131519601.html"
  },
  {
    "title": "With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns",
    "link": "https://finance.yahoo.com/news/67-institutional-ownership-pfizer-inc-130012784.html"
  },
  {
    "title": "Stocks That Pay Almost 10% Dividend Yields: Dow and Lyondell",
    "link": "https://finance.yahoo.com/m/4f836d30-d632-3681-8575-9bd09d591ef9/stocks-that-pay-almost-10-.html"
  },
  {
    "title": "Sanofi Q1 Earnings Top Estimates, Dupixent Drives Sales Growth",
    "link": "https://finance.yahoo.com/news/sanofi-q1-earnings-top-estimates-115900224.html"
  },
  {
    "title": "2 No-Brainer Stocks to Buy With Less Than $30",
    "link": "https://finance.yahoo.com/news/2-no-brainer-stocks-buy-104500799.html"
  },
  {
    "title": "Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know",
    "link": "https://finance.yahoo.com/news/pfizer-pfe-stock-sinks-market-214517376.html"
  },
  {
    "title": "Pfizer Declares Second-Quarter 2025 Dividend",
    "link": "https://finance.yahoo.com/news/pfizer-declares-second-quarter-2025-204000919.html"
  },
  {
    "title": "Why Is Summit Therapeutics Stock Soaring On Wednesday?",
    "link": "https://finance.yahoo.com/news/why-summit-therapeutics-stock-soaring-194743694.html"
  },
  {
    "title": "Pfizer Advances Bold Vision for Future of Cancer Care at the ASCO 2025 Annual Meeting",
    "link": "https://finance.yahoo.com/news/pfizer-advances-bold-vision-future-194600237.html"
  },
  {
    "title": "Why vaccine makers aren't worried about Trump administration cuts",
    "link": "https://finance.yahoo.com/news/why-vaccine-makers-arent-worried-about-trump-administration-cuts-185027024.html"
  }
]